Since its establishment, TRE I has always shown a great interest in research and development - demonstrated
by the creation of an in-house multidisciplinary group of veterinarians, biologists
and pharmacologists mainly dedicated to researching and developing innovative
and effective products in the fields of therapies, preparations and advanced formulations.
TRE I’s success in research and development is also the result of its ability in net-working
and collaborating with both Italian and European universities, laboratories and
product development centres, which are working on innovative medicines and using
the most sophisticated and advanced methodologies currently involved in pharmaceutical
research.
The company invests a significant part of its resources in the research and development
of new products which are at one and the same time remarkable for the highly innovative
therapies involved and the cutting-edge technology used.
During the last few years TRE I has developed and brought innovative pharmaceutical products to the market.
The line of microencapsulated products and the products based on MLP (Multi-Layer
Protection) technology are a clear example of this dedication.
Besides being rewarded with a specific patent, these product lines have also
met with considerable success on the market: in acknowledgement of the company’s
innovative capabilities, TRE I has been chosen by its clients as their partner, making it a recognised and reliable
brand on both the Italian and international markets.
